The Servier case: The game isn’t over yet -
The European Court of Justice recently issued seven judgments in the landmark "Servier" case, confirming the anticompetitive nature of "pay-for-delay" agreements between...more
The Administrative Supreme Court upholds decisions restricting the prescription of a treatment against osteoporosis.
Upon the assessment of a follow-up study, the French National Authority for Health (“HAS”) recommended...more
On 9 September 2020, the French Competition Authority (“FCA”) issued an infringement decision sanctioning Novartis and Roche with record fines for the pharmaceutical sector in France, totaling 444 million euros, for having...more
1/28/2021
/ Biotechnology ,
Competition ,
Enforcement Actions ,
France ,
French Competition Authority ,
Genentech ,
Infringement ,
Life Sciences ,
Novartis ,
Off-Label Use ,
Pharmaceutical Industry
In three recent judgments issued on 5 October 2020, the General Court of the European Union ("GCEU") partially annulled the European Commission’s ("Commission") decisions of February 2017 which had authorized onsite...more
10/22/2020
/ Annulment ,
Antitrust Investigations ,
Corporate Counsel ,
Dawn Raids ,
EU ,
European Commission ,
Evidentiary Standards ,
Exchange of Information ,
France ,
General Court of the European Union (GCEU) ,
Lack of Authority ,
Standard of Proof ,
Supermarkets